PARIS — Azzalure, which is touted as a French rival to Botox, has been approved for sale in the U.K. The muscle relaxant for aesthetic use, which is said to temporarily improve the appearance of moderate to severe vertical lines between the eyebrows, was developed by Ipsen and is commercialized by Galderma, the venture between L’Oréal and Nestlé. Azzalure will be available commercially in the U.K. by the end of the second quarter of this year. The product has gotten the collective nod from 15 European countries’ health authorities.
"I think that all anyone really wants in life is to have people understand us for who we actually are, despite everything," says Ruth Negga. The actress talks "Preachers" season 2 and more on WWD.com. #wwdeye (📷: Dan Doperalski)
"That's something that resonates with me too because I'm so locked into a number. If I go over that number it completely ruins my day so it's nice to get detached from the number on the scale." - Chelsea Handler on Kelly LeVeque's book "Body Love." #wwdeye (📷: John Salangsang)